
Breakthroughs that change patients' lives.
[SC] Specialty Care Inline Portfolio & LCM Strategy Lead
Job Title: Specialty Care Inline Portfolio & LCM Strategy Lead, Specialty Care Japan Reporting Line:
Report to Specialty Care TA lead
Position Purpose:
-
The Specialty Care Inline Portfolio & LCM Strategy Lead is accountable for end-to-end lifecycle and portfolio strategy for inline Specialty Care products in Japan, especially at the important milestones such as; new indication added, new formulations, or pre-LOE planning
-
This role integrates Life Cycle Management (LCM) with portfolio-level strategic planning, ensuring sustained value delivery across products while proactively managing risks and identifying opportunities with financial impact.
-
The role acts as a project manager (PMO) or a project lead representing SC commercial team, or single point of coordination, aligning Global / ICO strategies with Japan-specific market realities, and enabling cross-functional teams to execute cohesive, forward-looking portfolio and lifecycle plans and execution.
-
Key Responsibilities(主な職務・責任)
-
Life Cycle Management (LCM) Leadership
-
Own the country-specific LCM strategy for inline products, aligned with Global / ICO LCM frameworks focusing on RD businesses (expected projects: new formulation, additional indications of RD business)
-
Lead scenario planning related to pre-post LOE, formulation evolution, and potential generic or biosimilar entry, with clear risks and mitigation actions. (expected projects: LOE forecasting for I&I and RD product)
-
Ensure organizational readiness for lifecycle transitions, including internal alignment, communication planning, and execution governance.
-
Portfolio Strategy & Planning
-
Own and drive the inline Specialty Care portfolio strategy in Japan, ensuring prioritization of resources and initiatives across products.
-
Develop and maintain a mid- to long-term portfolio roadmap, integrating commercial, medical, access, and regulatory perspectives.
-
Translate Global / ICO portfolio and brand strategies into Japan-optimized plans, reflecting local pricing rules, access pathways, and competitive landscape.
-
Assist SC commercial leads or brand leads, as well as SC TA lead at OP process to work closely with Finance team as an overall SC portfolio planning
-
Commercial & Transition Readiness
-
Support formulation or new indication launches or transitions (e.g., line extensions, formulation changes) in close collaboration with brand and functional teams, working closely with launch excellence team where applicable.
-
Risk Management & Escalation
-
Watch carefully market/regulation changes to Identify, track, and proactively mitigate portfolio- and LCM-critical risks, such as pricing erosion rule changes, substitution exposure, and access disruption.
-
Escalate issues early with clear options and recommendations, enabling timely decision-making at country and above-market levels.
-
Required Skills & Experience(必要なスキル・経験)
-
Behavioral / Leadership Skills
-
Strong strategic thinking with the ability to connect portfolio, brand, and lifecycle perspectives
-
Proven ability to lead cross-functional teams without direct authority and drive alignment across diverse stakeholders. Team worker.
-
High level of self-awareness, accountability, and agility, with comfort operating in ambiguity and change.
-
Learning agility. Willing to learn new things, new way of approaches, and learn from others.
-
Influential leadership
-
Technical & Functional Skills
-
Logical thinking and strategic mindset
-
Strong business case/financial case development skills, including fair knowledge around financial acumen.
-
Project management skills and experiences
-
Solid communication skills both in Japanese and in English at business level.
-
Preferably some level of experience in brand and portfolio strategy development, grounded in market analysis and customer insights.
-
Preferably some level of understanding of pharmaceutical lifecycle management, including pricing, access, and competitive dynamics.
-
Experience
-
5+ years of experience in the pharmaceutical industry, with roles in marketing, portfolio strategy, or lifecycle management preferred.
-
Or some background of consultancy work at health care industries.
-
Experience in aunch preparation and/or major lifecycle transitions is highly preferred
-
Experience in any diseases in Specialty care is a plus.
-
Language
Business-level proficiency in Japanese and English (written and verbal)
Work Location Assignment: On Premise
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
Marketing and Market Research:
浏览量
1
申请点击
0
Mock Apply
0
收藏
0
相似职位

Product Manager, Rare Disease Marketing, Rare Disease Business Unit
Amgen · Japan - Tokyo

Manager, Product, GDI
Coca-Cola · Japan - Tokyo

Consumption Lead, Data360 and Agentforce
Salesforce · Japan - Tokyo

Director, Strategy & Programs
Salesforce · Japan - Tokyo

Director, Consumer & Category Insights
Coca-Cola · Japan - Tokyo
关于Pfizer

Pfizer
PublicPfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer (1824–1906) and Charles F.
10,001+
员工数
New York City
总部位置
$280B
企业估值
评价
10条评价
4.0
10条评价
工作生活平衡
3.2
薪酬
4.3
企业文化
4.1
职业发展
3.4
管理层
3.5
72%
推荐率
优点
Good salary and competitive compensation
Supportive management and team collaboration
Innovative and interesting projects
缺点
High workload and overwhelming demands
Long hours and fast-paced environment
Limited career advancement opportunities
薪资范围
11 个数据点
Junior/L3
L3
Junior/L3 · Product Manager
0份报告
$150,000
年薪总额
基本工资
$125,000
股票
$10,000
奖金
$15,000
$127,500
$172,500
面试评价
4条评价
难度
3.0
/ 5
时长
14-28周
面试流程
1
Application Review
2
HR Screen
3
HireVue Video Interview
4
Hiring Manager Interview
5
Final Interview/Panel
6
Offer Decision
常见问题
Behavioral/STAR
Past Experience
Culture Fit
Technical Knowledge
Case Study
最新动态
A patent win for Pfizer and BridgeBio - statnews.com
statnews.com
News
·
1w ago
Pfizer settles with 3 generics firms over Vyndamax - The Pharma Letter
The Pharma Letter
News
·
1w ago
Pfizer's blood cancer drug meets main goal in late-stage trial - Reuters
Reuters
News
·
1w ago
Pfizer's blood cancer drug meets main goal in late-stage trial - Yahoo
Yahoo
News
·
1w ago